Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 73 | ECE2021 | Next issue

European Congress of Endocrinology 2021

Online
22 May 2021 - 26 May 2021

Card image cap
The European Congress of Endocrinology provides a global platform for the international endocrine community to discuss the latest advances in the field.

Presented Eposters

Presented ePosters 9: Endocrine-Related Cancer

ea0073pep9.1 | Presented ePosters 9: Endocrine-Related Cancer | ECE2021

Long-term prognosis in patients with insulinoma

Elina Peltola , Päivi Hannula , Huhtala Heini , Metso Saara , Sand Juhani , Laukkarinen Johanna , Tiikkainen Mirja , Sirén Jukka , Soinio Minna , Nuutila Pirjo , Moilanen Leena , Laaksonen David E. , Ebeling Tapani , Arola Johanna , Schalin-Jäntti Camilla , Jaatinen Pia

IntroductionInsulinomas are the most common functional neuroendocrine tumours of the pancreas. Because previous data on the long-term prognosis of insulinoma patients are scarce, we wanted to study the morbidity and mortality in Finnish patients previously treated for an insulinoma.Patients and methodsThe Finnish insulinoma register consists of all adult patients diagnosed with an insulinoma in Finland during...

ea0073pep9.2 | Presented ePosters 9: Endocrine-Related Cancer | ECE2021

Possible role of common RET polymorphisms in pheochromocytoma

Skalniak Anna , Rzepka Ewelina , Przybylik-Mazurek Elwira , Hubalewska-Dydejczyk Alicja

BackgroundIn about 2/3 of pheochromocytoma patients, no pathogenic germline variant can be identified that might be responsible for the onset of the disease. However, in many patients, we observe the repeated appearance of one or more common polymorphisms in the gene RET. Each of them has been shown to be of no significance for pheochromocytoma and multiple endocrine neoplasm type 2 development, when analysed individually. We decided to test whe...

ea0073pep9.3 | Presented ePosters 9: Endocrine-Related Cancer | ECE2021

Pneumocystis pneumonia following surgical resection of pulmonary carcinoid causing ectopic ACTH syndrome: a case report

Eugénie Van Mieghem , Nowé Vicky , Leyn Paul De , Decaluwé Herbert , Timon Vandamme , Abrams Pascale

BackgroundCushing’s syndrome due to ectopic ACTH secretion only accounts for 10% of all cases of Cushing’s syndrome and is most often associated with pulmonary neuro-endocrine tumors. Treatment of ectopic ACTH syndrome is predominantly surgical with resection of the tumor. Following resolution of hypercortisolism, previously subclinical Pneumocystis jiroveci infection can become overt due to restored immune response.Clini...

ea0073pep9.4 | Presented ePosters 9: Endocrine-Related Cancer | ECE2021

Parathyroid carcinoma presenting as ventricular bigeminy in pregnancy

Gumber Leher , Sivasankaran Karthikeyan , Shoaib Khan Sardar Muhammad

IntroductionParathyroid carcinoma is a very rare phenomenon with an estimated prevalence of 0.005% of all cancers. There have been fewer than ten cases of parathyroid carcinoma in pregnancy previously reported in literature. Clinical features are similar to primary hyperparathyroidism and the diagnosis is usually made on surgery or histology. We present a unique case of parathyroid carcinoma in pregnancy where ventricular bigeminy was the presenting feat...

ea0073pep9.5 | Presented ePosters 9: Endocrine-Related Cancer | ECE2021

Endothelial and vascular function, biomarkers and clinical presentation in patients with small intestine NETs

Kostiainen Iiro , Rosengård-Bärlund Milla , Karppinen Noora , Simonen Piia , Rapola Janne , Lindén Riikka , Schalin-Jäntti Camilla , Matikainen Niina

Background20–30% of patients with metastatic small intestine neuroendocrine tumours (SI-NETs) suffer from carcinoid syndrome (CS), i.e. diarrhea, flushing, and bronchospasm. Of these, 25–50% develop carcinoid heart disease (CHD) characterized by valve fibrosis and right heart failure. There are no early predictive markers of CHD, which typically is diagnosed in the advanced stage.Aims of the studyTo...

ea0073pep9.6 | Presented ePosters 9: Endocrine-Related Cancer | ECE2021

Characterization of signaling pathways and molecular mechanisms underlying kisspeptin response in pancreatic neuroendocrine tumor (panNETs) cells

Antonio C Fuentes-Fayos , Emilia Alors-Pérez , Sergio Pedraza Arévalo , Aura D. Herrera-Martínez , Jose Angel Días-Pérez , Teresa Caro , MARIA Angeles Galvez Moreno , Raul M Luque , Antonio Jesús Martínez-Fuentes

Pancreatic neuroendocrine tumors (panNETs) comprise several neoplasms in which a precise diagnosis and therapeutic treatment are hampered by their diversity and heterogeneity which in turn, hind the identification of common molecular signatures and the development of efficient therapeutic approaches. Subsequently, there are no clinical, biochemical, anatomopathological, immunohistochemical or molecular features capable to currently predict either tumor prognosis or post-surgic...

ea0073pep9.7 | Presented ePosters 9: Endocrine-Related Cancer | ECE2021

Hypercalcaemia due to ovarian small cell carcinoma of the hypercalcaemic type (SCCOHT)

Montebello Annalisa , Gruppetta Mark

BackgroundHypercalcaemia is commonly encountered during clinical practice. SCCOHT is a rare ovarian malignancy typically found in young women. In two thirds of patients, it causes a paraneoplastic hypercalcaemia which is usually asymptomatic.Case ReportA thirty-seven-year-old lady, presented to casualty with a one -week history of worsening nausea, vomiting, anorexia, abdominal pain, polydipsia, and polyuria....

ea0073pep9.8 | Presented ePosters 9: Endocrine-Related Cancer | ECE2021

Outcomes of a multicenter surveillance protocol in asymptomatic Succinate Dehydrogenase (SDH) B and C mutation carriers

Romero LLuch Ana R. , Disotuar Suset Dueñas , Tous Romero Marai C. , Fernández Peña J. Ignacio , Cuenca Cuenca J. Ignacio , Elena Navarro

IntroductionBased on the evidence available back then, in 2015 we developed a provincial multicenter protocol for screening and follow up of no-index patients with SDHB and SDHC mutations.Objectives1. To evaluate the performance of the protocol designed for the follow-up of asymptomatic SDHB and C carriers. 2. To describe the penetrance of manifestations associated with hereditary PGL-FEO syndromes type 3 and...